$KURA Kura Oncology, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Kura Oncology, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Kura Oncology, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Kura Oncology, Inc. for free.

CIK Number: 0001422143
IRS Number: 611547851
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: KURA
Company Address: 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO 92121
Phone number: (858) 500-8800
Former name: ZETA ACQUISITION CORP III, date of change: 2007-12-27

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Market Capitalization: $124.74M
Prev close: $6.20
Average Daily Volume: 27,332
Days Low: $6.20
Year Low: $2.50
Year High: $7.24

Kura Oncology, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
GRASSO MARCCFO, CBO00Aug 22 20183 months ago
Szela Mary TDirector00Nov 08 201810 days ago
WILSON TROY EDWARDPresident and CEO59,026365,961shares bought: 54,026 / shares sold: 0 STRONG BUYNov 09 20189 days ago

View all Kura Oncology, Inc. insiders.

Kura Oncology, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 09 2018KURAKura Oncology, Inc ...WILSON TROY EDWARDPresident and CEOOption ExerciseM4.8026,041124,99765,974
Nov 09 2018KURAKura Oncology, Inc ...WILSON TROY EDWARDPresident and CEOBuyM4.8026,041124,99759,02633 K to 59 K (+78.95 %)
Nov 08 2018KURAKura Oncology, Inc ...Szela Mary TDirectorOption ExerciseA11.557,58387,5847,583
Nov 08 2018KURAKura Oncology, Inc ...Szela Mary TDirectorOption ExerciseA11.5530,000346,50030,000
Aug 22 2018KURAKura Oncology, Inc ...GRASSO MARCCFO, CBOOption ExerciseA19.40250,0004,850,000250,000
Jul 03 2018KURAKura Oncology, Inc ...FARNAM JOHNChief Operating Off ...Option ExerciseA18.45115,0002,121,750115,000
Jun 08 2018KURAKura Oncology, Inc ...Stein Steven HDirectorOption ExerciseA16.3513,000212,55013,000
Jun 08 2018KURAKura Oncology, Inc ...Malley ThomasDirectorOption ExerciseA16.3513,000212,55013,000
Jun 08 2018KURAKura Oncology, Inc ...Hasnain FaheemDirectorOption ExerciseA16.3513,000212,55013,000
Jun 08 2018KURAKura Oncology, Inc ...HOFFMAN ROBERTDirectorOption ExerciseA16.3513,000212,55013,000
Jan 26 2018KURAKura Oncology, Inc ...REN PINGDASVP Chemistry&Pharm ...Option ExerciseA20.0043,000860,00043,000
Jan 26 2018KURAKura Oncology, Inc ...North AnnetteSVP, General Counse ...Option ExerciseA20.0070,0001,400,00070,000
Jan 26 2018KURAKura Oncology, Inc ...HENSON HEIDIChief Financial Off ...Option ExerciseA20.0081,0001,620,00081,000
Jan 26 2018KURAKura Oncology, Inc ...GUALBERTO ANTONIOHead of Development ...Option ExerciseA20.00100,0002,000,000100,000
Jan 26 2018KURAKura Oncology, Inc ...WILSON TROY EDWARDPresident and CEOOption ExerciseA20.00275,0005,500,000275,000

View all Kura Oncology, Inc. insider transactions.